Literature DB >> 23180604

Survivin downregulation is not required for T antigen knockdown mediated cell growth inhibition in MCV infected merkel cell carcinoma cells.

David Schrama, Sonja Hesbacher, Jürgen C Becker, Roland Houben.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23180604     DOI: 10.1002/ijc.27962

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  5 in total

1.  Tumor vascularization and clinicopathologic parameters as prognostic factors in merkel cell carcinoma.

Authors:  A Bob; F Nielen; J Krediet; J Schmitter; D Freundt; D Terhorst; J Röwert-Huber; J Kanitakis; E Stockfleth; Ch Ulrich; M Weichenthal; F Egberts; B Lange-Asschenfeldt
Journal:  J Cancer Res Clin Oncol       Date:  2017-06-21       Impact factor: 4.553

Review 2.  Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC.

Authors:  Jürgen C Becker; Andreas Stang; Axel Zur Hausen; Nicole Fischer; James A DeCaprio; Richard W Tothill; Rikke Lyngaa; Ulla Kring Hansen; Cathrin Ritter; Paul Nghiem; Christopher K Bichakjian; Selma Ugurel; David Schrama
Journal:  Cancer Immunol Immunother       Date:  2017-11-30       Impact factor: 6.968

Review 3.  Effect of the Large and Small T-Antigens of Human Polyomaviruses on Signaling Pathways.

Authors:  Ugo Moens; Andrew Macdonald
Journal:  Int J Mol Sci       Date:  2019-08-12       Impact factor: 5.923

4.  Response of Merkel cell polyomavirus-positive merkel cell carcinoma xenografts to a survivin inhibitor.

Authors:  Lindsay R Dresang; Anna Guastafierro; Reety Arora; Daniel Normolle; Yuan Chang; Patrick S Moore
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.752

5.  Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy.

Authors:  Gerald Goh; Trent Walradt; Vladimir Markarov; Astrid Blom; Nadeem Riaz; Ryan Doumani; Krista Stafstrom; Ata Moshiri; Lola Yelistratova; Jonathan Levinsohn; Timothy A Chan; Paul Nghiem; Richard P Lifton; Jaehyuk Choi
Journal:  Oncotarget       Date:  2016-01-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.